Blogs about: Norvatis
Featured Blog
Big Pharma and Biotech companies continue to cut marketing spending in US
We’ve been covering this topic for a while now. Correctly I may add (see earlier post) http://57thstresearch.wordpress.com/2011/09/16/e-detailing-and-cloud-ipad-are-changing-in-pharma-gene… more →
57thstresearchandnews
Balancing the right to access with the need to innovate
wrote 1 month ago: The world’s poorest have been given an open ticket to access the latest innovative drugs. Their gove … more →
Big Pharma and Biotech companies continue to cut marketing spending in US
wrote 1 year ago: We’ve been covering this topic for a while now. Correctly I may add (see earlier post) h … more →
Stalwart Health Care Large Caps need the following characteristics
wrote 1 year ago: Our mid and large cap pharma 2012 picks have the following market characteristics 1) Predictable Ear … more →
CVS/Caremark PBM's drops drugs and ramps up strategy of promoting generics over brand name pharma! Branded Pharma fits back with co-pay rebates
wrote 1 year ago: Generic Company Teva We told you about 6 months ago that coupons/rebates were a major new strategy t … more →
Norvartis has upside but patent expirations are a cause of investor concern
wrote 1 year ago: In on corner we have a 54 Billion dollar diversified pharma juggernaut with 4% dividend yield 147 dr … more →
Norvartis turns to social media for it's Excedrin branding campaign
wrote 1 year ago: We told you back in December that the pharma industry would start slowly with customer outreach and … more →
Abbott is splitting in Two Next?
wrote 1 year ago: Abbot is splitting into two companies in early 2012. What does it mean for investors. Abbott had to … more →
Teva's biologics entry into the generic and branded pharma market will cause further disruption
wrote 1 year ago: We have an interesting ideas for small cap biotech pharma Generic biologicals. All the biologicals ( … more →
Japanese Drug Market top 3 in Market Share is changing
wrote 1 year ago: Japanese Drug market $100 billion is second in the world behind the US. Yet the top 3 in market shar … more →
Sorrell vs. IMF Health goes deep inside business of pharma data mining techniques
wrote 1 year ago: There is a landmark case that speaks to the hot button issue of PRIVACY. The case challenges a Vermo … more →
Technology Investments are changing clinical studies in Pharma and Biotech
wrote 2 years ago: Changing Technology is innovating drugmakers supply chain Health information access is changing the … more →
Pfizer buys King Pharma for 3.6B Transformational for PFE??
— 1 comment
wrote 2 years ago: A 40% premium paid for king? Did Pfizer overpay? Pfizer Acquires Pain Drug Maker King for $3.6 Billi … more →
Before you take that H1N1 vaccine shot to go anywhere....
wrote 2 years ago: Whether you are going places to travel/ study/ work, do you really need the H1N1 shot? I’m ama … more →
Norvartis earnings up driven by generics unit Sandoz
wrote 2 years ago: Novartis ups sales view as quarterly profit climbs 19% The Basel-based company (NVS 51.41, +0.66, +1 … more →
Prostate Cancer Patients Face Yearlong Rationing of Provenge
wrote 2 years ago: Demand is high and company cannot keep up with demand for “blockbuster” drug breakthru! … more →
Novartis (Ticker:NVS) Gains Support for First Pill to Treat MS! What this really means
wrote 2 years ago: Ok so Novartis recently won a U.S. panel’s backing to introduce the first pill to treat multiple scl … more →
Sprycel vs. Norvatis Gleevec- BMS cancer drugs show promise for skin and blood malignancies
— 1 comment
wrote 2 years ago: “Patients taking ipilimumab alone lived an average of 10.1 months, according to the study, alm … more →
J&J (JNJ) and Novartis (NOVN) beat estimates but Wall Street not impressed. Why?
wrote 3 years ago: J&J and the recall at McNeil have hurt the stock’s rally. J&J is not a “growth s … more →
Norvatis Vs. India: A Case agaisnt humanity
wrote 6 years ago: Significant Signatures. “Pharmaceutical company Novartis is taking the Indian government to co … more →
